CDC NIP/NIC Home Page
|
Count Basie B
| |||
I2: Vaccine Risk Communications: Overview and Development of Evidence-Based Educational Materials | |||
Workshop presenters will discuss vaccine risk communication in the United States and the ongoing need for tailored, evidence-based vaccine risk communication materials. Two example projects will be highlighted. | |||
Moderator: | Allison Kennedy | ||
2:00 PM | Introductory Remarks | ||
2:05 PM | 64 | Vaccine Risk Communication in the United States, 1992-2006: A Review Stephanie A. Irving, Daniel A. Salmon | |
2:20 PM | 65 | Testing messages that address urban African Americans concerns about influenza vaccine safety and efficacy K. Jupka, Ricardo Wray, Christina Lapka, Heather Jacobsen | |
2:35 PM | 66 | Development of an intervention for parents considering an exemption Deborah Gust, Allison Kennedy, Deanne Weber, Geoff Evans, Yuan Kong, Daniel Salmon | |
2:50 PM | Discussion |